The latest closing stock price for Intra-Cellular Therapies as of March 25, 2025 is 131.70.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,780 today, roughly 8 times their original investment - a 21.84% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 131.70 on March 24, 2025.
The Intra-Cellular Therapies 52-week high stock price is 131.79, which is 0.1% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 64.09, which is 51.3% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 86.46.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $7,780 today, roughly 8 times their original investment - a 21.84% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 131.70 on March 24, 2025.
The Intra-Cellular Therapies 52-week high stock price is 131.79, which is 0.1% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 64.09, which is 51.3% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 86.46.